Are all products from the altona® PCR reagent portfolio still available?
Yes! In view of the current exceptional situation and the extremely high demand for RealStar® SARS-CoV-2 RT-PCR Kit 1.0 short delays in the processing of orders for that kit may occur. All other detection kits are currently unaffected.
How does altona® meet the continuously high demand for test kits for SARS-CoV-2?
altona® responds to the changed requirements with various targeted measures. Capacities were increased by growing the team and extending the work space. Additionally, simple adaptations in product design (384 instead of 96 reactions per kit) and continuous optimization of internal processes allowed us to effectively increase production capacity.
Does altona® expect problems in the supply of raw materials for the PCR kits?
altona® does not expect bottlenecks for the supply of critical raw materials. Many essential PCR kit components are produced in-house in altona® facilities. For the remaining critical raw materials our suppliers and we worked out solutions to secure the flow of goods to be able to carry on production and supply our customers with the much-needed detection kits.
Are development and launch of further products planned?
The RealStar® SARS-CoV-2 RT-PCR Kit 1.0 is CE-IVD marked since April 30th 2020. A dedicated AltoStar® version (AltoStar® SARS-CoV-2 RT-PCR Kit 1.5) is under development and foreseen to be launched together with a corresponding kit for influenza virus detection (AltoStar® Influenza Screen & Type RT-PCR Kit 1.5).
Are there any shippment restrictions at present? Are delays to be expected?
Land transport in Europe is not affected. Air freight capacities have been reduced globally. altona® is working together with freight forwarders to ensure the products reach all destinations. We are in close contact with all our customers to ensure deliveries arrive in due time.
Is an increase in prices to be expected given the current situation?
Certainly not! Our prices are stable and will not change in the foreseeable future.